Xenon Pharmaceuticals
XENE
XENE
81 hedge funds and large institutions have $431M invested in Xenon Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.25% more ownership
Funds ownership: 79.79% → 80.04% (+0.25%)
Holders
81
Holding in Top 10
1
Calls
$3K
Puts
–
Top Buyers
| 1 | +$5.77M | |
| 2 | +$5.39M | |
| 3 | +$4.58M | |
| 4 |
Bank of New York Mellon
New York
|
+$3.11M |
| 5 |
Goldman Sachs
New York
|
+$1.17M |
Top Sellers
| 1 | -$6.64M | |
| 2 | -$3.75M | |
| 3 | -$3.7M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.38M |
| 5 |
Renaissance Technologies
New York
|
-$2.05M |